$ cat ./records/funded-nutritious-rice-and-cassava-with-tenfold-more-beta-caroten-2011.txt
Funded nutritious rice and cassava with tenfold more beta-carotene to fight vitamin A deficiency
[RECORD.TXT] · cat --full
The Gates Foundation funded the BioCassava Plus project and nutritionally enhanced rice varieties designed to combat vitamin A deficiency — which causes blindness in hundreds of thousands of children annually and increases mortality from diarrhoea, measles, and malaria. BioCassava Plus cassava varieties expressed ten times more beta-carotene than conventional varieties, along with improved iron, protein, and virus resistance. The nutritionally enhanced rice project aimed to reach hundreds of millions of people in Asia for whom rice is a dietary staple. Both initiatives addressed malnutrition through the crops people already grow, without requiring dietary or behavioral change.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Co-funded USAID WASH for Life program — $17 million matching grant for clean water innovations
Next →
First met Jeffrey Epstein at Manhattan townhouse after his aggressive lobbying campaign
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.